Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 18 May 2021
Biden pledges to export millions of FDA authorised vaccines
18 May 2021 - President says U.S. will have enough for entire population. ...
Posted by Michael Wonder on 18 May 2021
Almost one-third of adult Australians say they’re unlikely to get COVID vaccination: survey
19 May 2021 - Almost one-third of adult Australians say they are unlikely to be vaccinated against COVID-19 in a ...
Posted by Michael Wonder on 18 May 2021
U.S. FDA accepts regulatory submission for sintilimab in combination with pemetrexed and platinum chemotherapy for the first-line treatment of people with non-squamous non-small cell lung cancer
18 May 2021 - Innovent Biologics and Eli Lilly today jointly announced that the U.S. FDA accepted for review a biologics ...
Posted by Michael Wonder on 18 May 2021
PHARMAC, dental funding crucial in Budget - National Party
18 May 2021 - Thursday's Budget is being promoted as a Covid-19 Recovery Budget. ...
Posted by Michael Wonder on 18 May 2021
CMS delays Medicare payments for breakthrough devices until December
17 May 2021 - Medicare coverage for FDA designated breakthrough medical devices will have to wait several more months, despite ...
Posted by Michael Wonder on 18 May 2021
PBS win to bring relief for people with migraine but concerns over limitations remain
16 May 2021 - For Devonport resident Nette Judson a migraine attack causes her to struggle to walk and talk ...
Posted by Michael Wonder on 17 May 2021
AffyImmune Therapeutics' AIC100 granted fast track designation for treating thyroid cancer
17 May 2021 - AffyImmune Therapeutics announced today that the US FDA granted fast track designation to its lead compound, AIC100, ...
Posted by Michael Wonder on 17 May 2021
Australian Medical Association urges over 50s to not wait for Pfizer COVID-19 vaccine
18 May 2021 - The Australian Medical Association has backed the NSW Premier in urging people aged over 50 who ...
Posted by Michael Wonder on 17 May 2021
One in four COVID vaccine doses distributed in Australia not yet administered, figures show
17 May 2021 - New figures show one in four COVID-19 vaccines available in Australia have not been administered, with GP ...
Posted by Michael Wonder on 17 May 2021
Sandoz Canada launches its 6th biosimilar with Inclunox and Inclunox HP (enoxaparin sodium solution for injection 100 mg/mL and 150 mg/mL (high potency))
17 May 2021 - New Sandoz biosimilar launch can potentially lower healthcare costs, especially for Canadian hospitals, as 75% of the ...
Posted by Michael Wonder on 17 May 2021
Statement on leronlimab
17 May 2021 - FDA recognizes the substantial public interest in medicines that are being studied for the prevention or treatment ...
Posted by Michael Wonder on 17 May 2021
New Zealanders living with cystic fibrosis wait for 'life changing' drug
16 May 2021 - Edward Lee and Reese Robertson both have cystic fibrosis. ...
Posted by Michael Wonder on 17 May 2021
The national health data registers are the way forward
17 May 2021 - The key to developing follow-up of medicines and medical technology products is the national health data registers, ...
Posted by Michael Wonder on 17 May 2021
US Supreme Court denies Sandoz petition to review biosimilar Erelzi (etanercept-szzs) case
17 May 2021 - Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of more affordable ...
Posted by Michael Wonder on 17 May 2021
More flexible storage conditions for BioNTech/Pfizer’s COVID-19 vaccine
17 May 2021 - EMA’s CHMP has recommended a change to the approved storage conditions of Comirnaty, the COVID-19 vaccine ...